Skip to main content
Log in

Legacy data sharing to improve drug safety assessment: the eTOX project

  • Comment
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Abstract

The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Obiol-Pardo, C. et al. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J. Chem. Inf. Model. 51, 483–492 (2011).

    Article  CAS  Google Scholar 

  2. Carbonell, P. et al. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data. ALTEX 34, 219–234 (2017)10.14573/altex.1602071.

    Article  PubMed  Google Scholar 

  3. Harvey, J. et al. Management of organic impurities in small molecule medicinal products: deriving safe limits for use in early development. Regul. Toxicol. Pharmacol. 84, 116–123 (2017)10.1016/j.yrtph.2016.12.011.

    Article  CAS  PubMed  Google Scholar 

  4. Carrió, P. et al. Applicability Domain Analysis (ADAN): a robust method for assessing the reliability of drug property predictions. J. Chem. Inf. Model. 54, 1500–1511 (2014).

    Article  Google Scholar 

  5. Hewitt, M. et al. Ensuring confidence in predictions: a scheme to assess the scientific validity of in silico models. Adv. Drug Deliv. Rev. 86, 101–111 (2015)10.1016/j.addr.2015.03.005.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding authors

Correspondence to Ferran Sanz or François Pognan.

Ethics declarations

Competing interests

Some of the authors are employed in the pharmaceutical industry or in small and medium-sized enterprises, as indicated in the author affliations.

Supplementary information

Supplementary information S1 (box)

eTOX-related web sites and publications (PDF 173 kb)

Related links

Related links

FURTHER INFORMATION

eTOX

eTOXlab

eTOXsys

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanz, F., Pognan, F., Steger-Hartmann, T. et al. Legacy data sharing to improve drug safety assessment: the eTOX project. Nat Rev Drug Discov 16, 811–812 (2017). https://doi.org/10.1038/nrd.2017.177

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.177

  • Springer Nature Limited

This article is cited by

Navigation